Trials / Not Yet Recruiting
Not Yet RecruitingNCT07104344
Study of CM355 in Patients With Systemic Lupus Erythematosus
A Single-center, Open-label, Single-arm Clinical Study to Observe the Safety and Efficacy of CM355 in the Treatment of Refractory Systemic Lupus Erythematosus
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Second Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE.
Detailed description
This study is designed to investigate the safety and efficacy of CM355 in patients with moderately to severely active SLE who are refractory to treatment, and to analyze its pharmacokinetic profile , pharmacodynamic effects, and immunogenicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CM355 | CM355 injection |
Timeline
- Start date
- 2025-09-25
- Primary completion
- 2026-04-01
- Completion
- 2026-10-01
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07104344. Inclusion in this directory is not an endorsement.